Flash Continuous Glucose Monitoring: A Summary Review of Recent Real-World Evidence

Research output: Contribution to journalArticlepeer-review


Optimizing glycemic control remains a shared challenge for clinicians and their patients with diabetes. Flash continuous glucose monitoring (CGM) provides immediate information about an individual's current and projected glucose level, allowing users to respond promptly to mitigate or prevent pending hypoglycemia or hyperglycemia. Large randomized controlled trials (RCTs) have demonstrated the glycemic benefits of flash CGM use in both type 1 and type 2 diabetes. However, whereas RCTs are mostly focused on the efficacy of this technology in defined circumstances, real-world studies can assess its effectiveness in wider clinical settings. This review assesses the most recent real-world studies demonstrating the effectiveness of flash CGM use to improve clinical outcomes and health care resource utilization in populations with diabetes.

Original languageEnglish
Pages (from-to)64-71
Number of pages8
JournalClinical diabetes : a publication of the American Diabetes Association
Issue number1
Publication statusPublished - 1 Jan 2021


Dive into the research topics of 'Flash Continuous Glucose Monitoring: A Summary Review of Recent Real-World Evidence'. Together they form a unique fingerprint.

Cite this